NVAX

NVAX EBITDA Growth

-141.49%TTM

Period ending:

NVAX TTM EBITDA YoY %%
NVAX TTM EBITDA YoY %753.08%-1286.78%
1997-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

NVAX ebitda growth history

Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 115 observations from Dec 31, 1997 to Jun 30, 2026.

Novavax Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-141.4858%
-107.5915%
555.6727%
289.5015%
317.1149%
264.6294%
77.8321%
56.5802%
57.3056%
69.4082%
19.4014%
60.2178%
61.9721%
11.8666%
64.0212%
-21.4802%
-53.5147%
-112.2892%
-322.4333%
-304.4951%
-1,089.371%
-500.0805%
-247.5663%
-95.2187%
50.6233%
38.7959%
29.7606%
20.493%
4.132%
1.342%
-1.9371%
1.1062%
13.9498%
27.6183%
38.3108%
42.0752%
26.6398%
-10.9331%
-69.8807%
-172.2024%
-178.6868%
-124.4757%
-89.4332%
-70.0415%
-59.8005%
-68.9786%
-62.7792%
-36.5709%
-53.7127%
-73.168%
-74.6012%
-100.0044%
-90.1541%
-52.5068%
-40.0208%
-6.0072%
27.8108%
32.6904%
40.6783%
50.8626%
33.9253%
25.8888%
5.7338%
-39.4037%
-25.8224%
-21.6373%
-8.1334%
-12.0689%
-21.9244%
-19.7246%
-16.85%
12.0812%
3.9926%
-8.1713%
-30.8286%
-277.4443%
-559.8829%
-1,005.8925%
-284.3399%
61.5891%
80.6875%
90.5307%
73.3969%
-44.3923%
-35.8358%
-75.4538%
-44.017%
9.5039%
20.2889%
34.3159%
30.4077%
11.4299%
-45.2037%
-122.4833%
-270.4995%
-124.122%
-38.0349%
21.2759%
52.5354%
-0.9462%

Compare ebitda growth

All NVAX financial metrics · NVAX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.